Wegovy

• 12/28/2024

  Tirzepatide Access in Jeopardy: Patients Face Uncertain Future

• 12/26/2024

  Obesity Drug Setback Sparks Retail Rush into Novo Nordisk

• 12/23/2024

  Merck Bets Big on Obesity Market with $2 Billion Weight Loss Pill Deal

• 12/21/2024

  Novo Nordisk’s Weight Loss Hope Falters: Shares Tumble 24%

• 12/9/2024

  Novavax Revamps Business: Sells Czech Facility for $200M, Shifts Focus to Vaccine Pipeline

• 12/8/2024

  Market Pulse: Winners, Losers, and Surprises

• 12/8/2024

  Zepbound vs Wegovy: New Obesity Treatment Wins in Head-to-Head Trial

• 11/13/2024

  Weight-Loss Giants Face Uncertainty: Can They Adapt to Changing Market?

• 11/12/2024

  Trump’s Victory Sparks Market Rally: Sectors Soar, Winners Emerge

• 11/9/2024

  Novo Nordisk’s Stock Sees Wild Swings: Guidance Disappoints